News | Heart Valve Technology | November 06, 2017
November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System
News | Heart Valve Technology | June 27, 2017
Mitralign Inc. announced the commencement of its SCOUT II study in Europe, with the Trialign System for the treatment...
Videos | Heart Valve Technology | June 14, 2017
A discussion with Rebecca Hahn, M.D., FASE, director of interventional echocardiography and professor of medicine at
News | Heart Valve Technology | November 18, 2016
Mitralign Reports First Transcatheter Tricuspid Repair in Patient with Cardiac Implantable Device Lead
Mitralign Inc. announced the successful compassionate use treatment of a patient suffering from tricuspid regurgitation...
News | Heart Valve Technology | October 28, 2016
Mitralign will present data on its Trialign Tricuspid Repair system at the 2016 Transcatheter Cardiovascular...
News | Heart Valve Technology | July 19, 2016
Mitralign Inc. announced last week it has completed subject enrollment in the SCOUT early feasibility study in the...
News | Heart Valve Technology | May 23, 2016
Mitralign Inc. announced it has raised $39.8 million to date in a Series E equity round of financing.
News | Annuloplasty Rings | April 27, 2016
Mitralign Inc. announced its Mitralign Percutaneous Annuloplasty System (MPAS) has received CE mark approval from its...
News | Heart Valve Technology | December 10, 2015
Mitralign Inc. announced the first U.S. subject has been enrolled in the SCOUT Study using the company’s Trialign (...
Feature | Heart Valve Technology | November 12, 2015 | Dave Fornell
(This article was updated in June 2018)